Granules India says it will strengthen its manufacturing oversight after a US FDA warning related to documentation practices and contamination concerns. The company plans to digitize workflows and automate record management to improve data accuracy and compliance. Granules is positioning the reforms as proactive steps to address regulatory pressure while maintaining product quality across its facilities.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
